0263-2136 < 0264-410X < 0265-6914

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by 0264-410X

Number of relevant bibliographic references: 396.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000353 (2019)	Rachael M. Porter [États-Unis] ; Shoshanna Goldin [Suisse] ; Kathryn E. Lafond [États-Unis] ; Lisa Hedman [Suisse] ; Mellissa Ungkuldee [États-Unis] ; Jordan Kurzum [États-Unis] ; Eduardo Azziz-Baumgartner [États-Unis] ; Claudia Nannei [Suisse] ; Joseph S. Bresee [États-Unis] ; Ann Moen [Suisse]	Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic
000369 (2019)	Kylie E. C. Ainslie [États-Unis, Royaume-Uni] ; Michael Haber [États-Unis] ; Walter A. Orenstein [États-Unis]	Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic
000511 (2018)	Jack Ferdman ; Giuseppe Palladino ; Hua-Xin Liao ; M. Anthony Moody ; Thomas B. Kepler ; Giuseppe Del Giudice ; Philip R. Dormitzer ; Stephen C. Harrison ; Ethan C. Settembre ; Pirada Suphaphiphat	Intra-Seasonal Antibody Repertoire Analysis of a Patient Immunized with an MF59®-adjuvanted Pandemic 2009 H1N1 Vaccine
000708 (2017)	Brian J. Lenny [États-Unis] ; Stephanie Sonnberg [États-Unis] ; Angela F. Danner [États-Unis] ; Kimberly Friedman [États-Unis] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] ; Jeremy C. Jones [États-Unis]	Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice
000737 (2017)	Tülin Morç L [États-Unis] ; Brett L. Hurst [États-Unis] ; E. Bart Tarbet [États-Unis]	Calcium Phosphate Nanoparticle (CaPNP) for Dose-Sparing of Inactivated Whole Virus Pandemic Influenza A (H1N1) 2009 Vaccine in Mice
000738 (2017)	Abigail Eaton [États-Unis] ; Ned Lewis [États-Unis] ; Bruce Fireman [États-Unis] ; John Hansen [États-Unis] ; Roger Baxter [États-Unis] ; Julianne Gee [États-Unis] ; Nicola P. Klein [États-Unis]	Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009–2010
000853 (2016)	Erin Sparrow [Suisse, Australie] ; Martin Friede [Suisse] ; Mohamud Sheikh [Australie] ; Siranda Torvaldsen [Australie] ; Anthony T. Newall [Australie]	Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications
000869 (2016)	Thomas J. Fitzgerald [États-Unis] ; Yoonjae Kang [États-Unis] ; Carolyn B. Bridges [États-Unis] ; Todd Talbert [États-Unis] ; Sara J. Vagi [États-Unis] ; Brock Lamont [États-Unis] ; Samuel B. Graitcer [États-Unis]	Integrating pharmacies into public health program planning for pandemic influenza vaccine response
000882 (2016)	David L. Gordon [Australie] ; Dimitar Sajkov [Australie] ; Yoshikazu Honda-Okubo [Australie] ; Samuel H. Wilks [Royaume-Uni] ; Malet Aban [Australie] ; Ian G. Barr [Australie] ; Nikolai Petrovsky [Australie]	Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
000885 (2016)	Leora R. Feldstein [États-Unis] ; Laura Matrajt [États-Unis] ; M. Elizabeth Halloran [États-Unis] ; Wendy A. Keitel [États-Unis] ; Ira M. Longini [États-Unis]	Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies
000A63 (2015)	Sophie Massin [France] ; Bruno Ventelou [France] ; Antoine Nebout-Javal [France] ; Pierre Verger [France] ; Céline Pulcini [France]	Cross-sectional survey: Risk-averse French general practitioners are more favorable toward influenza vaccination
000B05 (2015)	Glen J. Nowak [États-Unis] ; Kristine Sheedy [États-Unis] ; Kelli Bursey [États-Unis] ; Teresa M. Smith [États-Unis] ; Michelle Basket [États-Unis]	Promoting influenza vaccination: Insights from a qualitative meta-analysis of 14 years of influenza-related communications research by U.S. Centers for Disease Control and Prevention (CDC)
000C12 (2015)	Yoshikazu Honda-Okubo [Australie] ; Chun Hao Ong [Australie] ; Nikolai Petrovsky [Australie]	Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
000E16 (2014)	Sharon E. Frey ; David I. Bernstein ; Rebecca C. Brady ; Wendy A. Keitel ; Hana El Sahly ; Nadine Georges Rouphael ; Mark J. Mulligan ; Robert L. Atmar ; Srilatha Edupuganti ; Shital M. Patel ; Michelle Dickey ; Irene Graham ; Edwin L. Anderson ; Diana L. Noah ; Heather Hill ; Mark Wolff ; Robert B. Belshe	Phase II Trial in Adults of Concurrent or Sequential 2009 Pandemic H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations
000F96 (2014)	Betul Buyuktiryaki [Turquie] ; Ozge Uysal Soyer [Turquie] ; Mustafa Erkocoglu [Turquie] ; Ayse Dogan [Turquie] ; Dilek Azkur [Turquie] ; Can Naci Kocabas [Turquie] ; Yildiz Dallar [Turquie] ; Ayfer Tuncer [Turquie] ; Bulent Enis Sekerel [Turquie]	What a pandemic teaches us about vaccination attitudes of parents of children with asthma
000F98 (2014)	Florent Valour [France] ; Laurent Cotte [France] ; Nicolas Voirin [France] ; Matthieu Godinot [France] ; Florence Ader [France] ; Tristan Ferry [France] ; Philippe Vanhems [France] ; Christian Chidiac [France]	Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients
001001 (2014)	Christopher C. Blyth [Australie] ; Peter C. Richmond [Australie] ; Peter Jacoby [Australie] ; Patrick Thornton [Australie] ; Annette Regan [Australie] ; Christine Robins [Australie] ; Heath Kelly [Australie] ; David W. Smith [Australie] ; Paul V. Effler [Australie]	The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children
001008 (2014)	Barry Buckland [États-Unis, Royaume-Uni] ; Robert Boulanger [États-Unis] ; Mireli Fino [États-Unis] ; Indresh Srivastava [États-Unis] ; Kathy Holtz [États-Unis] ; Nikolai Khramtsov [États-Unis] ; Clifton Mcpherson [États-Unis] ; Jamal Meghrous [États-Unis] ; Paul Kubera [États-Unis] ; Manon M. J. Cox [États-Unis]	Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process
001009 (2014)	Carlo Davila-Payan [États-Unis] ; Julie Swann [États-Unis] ; Pascale M. Wortley [États-Unis]	System factors to explain 2009 pandemic H1N1 state vaccination rates for children and high-risk adults in US emergency response to pandemic
001011 (2014)	Michael Pfleiderer [Allemagne] ; Jean-Hugues Trouvin [France] ; Daniel Brasseur [Belgique] ; Marta Gr Nstrom [Suède] ; Ragini Shivji [Royaume-Uni] ; Manuela Mura [Royaume-Uni] ; Marco Cavaleri [Royaume-Uni]	Summary of knowledge gaps related to quality and efficacy of current influenza vaccines
001012 (2014)	Ishrat Sultana [États-Unis] ; Kevin Yang [États-Unis] ; Melkamu Getie-Kebtie [États-Unis] ; Laura Couzens [États-Unis] ; Lewis Markoff [États-Unis] ; Michail Alterman [États-Unis] ; Maryna C. Eichelberger [États-Unis]	Stability of neuraminidase in inactivated influenza vaccines

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "0264-410X" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "0264-410X" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0264-410X
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021